What Happened?
Ann Arbor, MI-based Millendo Promoted Jeffery Brinza as Chief Administrative Officer and General Counsel
Date of management change: June 28, 2018
Ann Arbor, MI-based Millendo Promoted Jeffery Brinza as Chief Administrative Officer and General Counsel
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing`s Syndrome (CS).
Jeffery M. Brinza is Chief Administrative Officer and General Counsel at Millendo. Previously, Jeffery held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Ware Deramus, Andreasson Roland, Cherney Nick, Wilson Chuck, Elder Allison, Powers Katie, Atkinson Casey, G. Debbie, Fehmel Chris, Rosen Jodi, Sealy Will
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.